Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

    Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano
    e2020042
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.042
    1655
    PDF: 1070
    HTML: 545
  • ANTIMICROBIAL OPTIMIZATION AFTER POSITIVE PNEUMOCOCCAL URINARY ANTIGEN TESTING IN HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA: A RETROSPECTIVE COHORT STUDY

    Maria Donga, Ana Gorgulho, Francisca Bartilotti, Dara Mbanze, Rita Menezes, Cristóvão Figueiredo, Joana Fragoso, Sofia Nunes, Daniel Coutinho, Gabriela Abreu, Tiago Teixeira, Luis Malheiro
    e2026081
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.081
    148
    PDF: 58
    Html: 28
  • CLINICAL SIGNS AND TREATMENT OF NEW-ONSET BONE MARROW FAILURE ASSOCIATED SARS-COV-2 INFECTION IN CHILDREN : A SINGLE INSTITUTION PROSPECTIVE COHORT STUD

    Mervat A M youssef, Ebtisam Shawky hmed, Dalia Tarik Kamal, khalid Elsayh,, Mai A Abdelfatta, Hyam Hassan Mahran Mahran, Mostafa M Embaby
    e2024034
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.034
    1379
    PDF: 1461
    HTML: 147
  • SEQUENCE ANALYSIS OF HOT SPOT REGIONS OF SPIKE AND RNA‑DEPENDENT‑RNA POLYMERASE (RDRP) GENES OF SARS-COV-2 IN KERMAN, IRAN

    Nasir, Ramin, Amin, Jamal
    e2023042
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.042
    1043
    PDF: 864
    HTML: 306
  • MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19

    XiaoTian Zhang, Yanhui Yu, Chao Zhang, Lijuan Zhao, Hongrui Wang, Guoqing Wang, Ming Yang
    e2022003
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.003
    2410
    PDF: 1228
    HTML: 443
  • SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

    Firas Kreidieh, Sally Temraz
    e2020078
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.078
    1653
    PDF: 1050
    HTML: 462
  • Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study

    Rukiyye Bulut, İbrahim Erayman, Ceren Eryılmaz Yaman, Bahar Kandemir, Pınar Belviranlı Keskin, Esma Kepenek Kurt, Özcan Çeneli
    e2026082
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.082
    205
    PDF: 76
    Suppl. Files: 19
    Html: 45
    Html Suppl. Files: 13
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    2005
    PDF: 1232
    HTML: 424
  • the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY.

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Laura Martinelli Martinelli, lisa malincarne, Martina Savoia, Anna Laura Spinelli, Daniela Francisci
    e2021061
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.061
    2140
    PDF: 513
    HTML: 260
  • NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2

    Mohsen Nakhaei, Zohreh-Al-Sadat Ghoreshi, Mohammad Rezaei Zadeh Rukerd, Hedyeh Askarpour, Nasir
    e2023059
    2023-10-16
    https://doi.org/10.4084/MJHID.2023.059
    1196
    PDF: 564
    HTML: 182
  • SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19

    Elisabetta Abruzzese, Luigia Luciano, Francesco D'Agostino, Malgorzata Monika Trawinska, Fabrizio Pane, Paolo de Fabritiis
    e2020031
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.031
    3521
    PDF: 1663
    HTML: 588
  • ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19

    Chiara Agrati, Veronica Bordoni, alessandra sacchi, germana grassi, nicola petrosillo, emanuele nicastri, franca del nonno, giampiero d'offizi, fabrizio palmieri, luisa marchioni, maria rosaria capobianchi, andrea antinori, giuseppe ippolito, Michele Bibas
    e2021016
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.016
    2082
    PDF: 851
    HTML: 265
  • Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

    Claudio Fozza
    e2024011
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.011
    1898
    PDF: 1480
    HTML: 204
  • Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

    Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti
    e2022043
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.043
    2132
    PDF: 688
    HTML: 273
  • SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy SARS CoV 2 in severe neurological patients

    Francesco Di Gennaro
    e2020063
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.063
    1269
    PDF: 795
    HTML: 292
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    3066
    PDF: 1064
    HTML: 682
  • HOW I APPROACH HEMATOLOGIC ABNORMALITIES IN HOSPITALIZED PATIENTS WITH INFECTIOUS DISEASES

    Michele Bibas
    e2026085
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.085
    150
    PDF: 135
    Html: 157
  • ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY   Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.

    Ming Tong, Xiquan Yan, Yu Jiang, Zhaoxia Jin, Shengjiao Zhu, Lianhong Zou, Yanjuan Liu, Qing Zheng, Guoqiang Chen, Ruifeng Gui Gui, Zhilan Zhou, Xiaotong Han, Jiangming He, Siqing Yin, Changchun Ma, Wen Xiao, Yong Zeng, Fang Chen, Yimin Zhu
    e2022033
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.033
    1494
    PDF: 832
    HTML: 441
  • Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19

    Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca
    e2020048
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.048
    3388
    PDF: 1993
    HTML: 1012
  • The risk of SARS-CoV-2 reinfection in Duhok city, Kurdistan Region of Iraq

    Nawfal R Hussein
    Page e2021035
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.035
    1376
    PDF: 631
    HTML: 461
  • Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience

    Roberta Laureana
    e2026090
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.090
    132
    PDF: 79
    Html: 42
  • EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies

    Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah , Azita Azarkeiva, Maryam Naderi , Sara Matin , Asghar Bazrafshan , Zohreh Zahedi , Afshan Shirkavand , Parisa pishdad, Vincenzo De Sanctis
    e2022026
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.026
    1911
    PDF: 818
    HTML: 257
  • Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption

    Judit Demeter, Julia Weisinger, Zsolt Nagy
    e2021022
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.022
    1631
    PDF: 603
    HTML: 283
  • Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination

    Claudio Ucciferri, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca
    e2022023
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.023
    2520
    PDF: 669
    HTML: 308
  • IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

    Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
    e2023029
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.029
    1746
    PDF: 1005
    HTML: 422
  • Simultaneous presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a patient with underlying germline homozygous STXBP2 Mutation.

    Dr Shilpa Gupta, Dr Amrita Rajendran , Dr Akanksha Chichra , Dr Ayubali Qureshi
    e2026043
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.043
    420
    PDF: 272
    HTML: 98
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    1365
    PDF: 1226
    HTML: 525
  • FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator

    Claudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, Katia Falasca
    e2025057
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.057
    3281
    PDF: 1143
    HTML: 3385
  • TYPICAL AND ATYPICAL PRESENTATION OF COVID-19 INFECTION IN CHILDREN IN THE TOP OF PANDEMIC IN MINIA GOVERNORATE (TWO CENTER EXPERIENCE)

    Madeha Abdalla Sayed, Mohamed Abdelhakeem
    e2022002
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.002
    3005
    PDF: 703
    HTML: 363
  • COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2

    Indira Jaxybayeva, Riza Boranbayeva, Sagira Abdrakhmanova, Raikhan Maitbassova, Pakhitkanym Ishuova, Dinagul Bayesheva, Nurila Maltabarova, Adyl Katarbayev, Kumisgul Umesheva, Tatyana Marshalkina, Lyazat Manzhuova, Gulnara Abdilova, Gulshat Alimkhanova, Gulmira Yerzhanova, Gulnara Bulabaeva, Nazgul Zhanuzakova, Svetlana Anokhina, Aigul Kuatbayeva, Gulnara Tashenova
    e2022064
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.064
    1275
    PDF: 660
    HTML: 405
1 - 30 of 30 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.